Cargando…

Prognostic Value of Pathological Personality Traits for Treatment Outcome in Anxiety and Depressive Disorders: The Leiden Routine Outcome Monitoring Study

Previous studies have failed to take baseline severity into account when assessing the effects of pathological personality traits (PPT) on treatment outcome. This study assessed the prognostic value of PPT (Dimensional Assessment of Personality Pathology–Short Form) on treatment outcome (Brief Sympt...

Descripción completa

Detalles Bibliográficos
Autores principales: van Eeden, Wessel A., van Hemert, Albert M., Giltay, Erik J., Spinhoven, Philip, de Beurs, Edwin, Carlier, Ingrid V.E.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Lippincott Williams & Wilkins 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9555756/
https://www.ncbi.nlm.nih.gov/pubmed/35471975
http://dx.doi.org/10.1097/NMD.0000000000001535
_version_ 1784806927274868736
author van Eeden, Wessel A.
van Hemert, Albert M.
Giltay, Erik J.
Spinhoven, Philip
de Beurs, Edwin
Carlier, Ingrid V.E.
author_facet van Eeden, Wessel A.
van Hemert, Albert M.
Giltay, Erik J.
Spinhoven, Philip
de Beurs, Edwin
Carlier, Ingrid V.E.
author_sort van Eeden, Wessel A.
collection PubMed
description Previous studies have failed to take baseline severity into account when assessing the effects of pathological personality traits (PPT) on treatment outcome. This study assessed the prognostic value of PPT (Dimensional Assessment of Personality Pathology–Short Form) on treatment outcome (Brief Symptom Inventory [BSI-posttreatment]) among patients with depressive and/or anxiety disorders (N = 5689). Baseline symptom level (BSI-pretreatment) was taken into account as a mediator or moderator variable. Results showed significant effects of PPT on outcome, of which Emotional Dysregulation demonstrated the largest association (β = 0.43, p < 0.001). When including baseline BSI score as a mediator variable, a direct effect (β = 0.11, p < 0.001) remained approximately one-third of the total effect. The effects of Emotional Dysregulation (interaction effect β = 0.061, p < 0.001) and Inhibition (interaction effect β = 0.062, p < 0.001), but not Compulsivity or Dissocial Behavior, were moderated by the baseline symptom level. PPT predicts higher symptom levels, both before and after treatment, but yields relatively small direct effects on symptom decline when the effect of pretreatment severity is taken into account.
format Online
Article
Text
id pubmed-9555756
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Lippincott Williams & Wilkins
record_format MEDLINE/PubMed
spelling pubmed-95557562022-10-19 Prognostic Value of Pathological Personality Traits for Treatment Outcome in Anxiety and Depressive Disorders: The Leiden Routine Outcome Monitoring Study van Eeden, Wessel A. van Hemert, Albert M. Giltay, Erik J. Spinhoven, Philip de Beurs, Edwin Carlier, Ingrid V.E. J Nerv Ment Dis Original Articles Previous studies have failed to take baseline severity into account when assessing the effects of pathological personality traits (PPT) on treatment outcome. This study assessed the prognostic value of PPT (Dimensional Assessment of Personality Pathology–Short Form) on treatment outcome (Brief Symptom Inventory [BSI-posttreatment]) among patients with depressive and/or anxiety disorders (N = 5689). Baseline symptom level (BSI-pretreatment) was taken into account as a mediator or moderator variable. Results showed significant effects of PPT on outcome, of which Emotional Dysregulation demonstrated the largest association (β = 0.43, p < 0.001). When including baseline BSI score as a mediator variable, a direct effect (β = 0.11, p < 0.001) remained approximately one-third of the total effect. The effects of Emotional Dysregulation (interaction effect β = 0.061, p < 0.001) and Inhibition (interaction effect β = 0.062, p < 0.001), but not Compulsivity or Dissocial Behavior, were moderated by the baseline symptom level. PPT predicts higher symptom levels, both before and after treatment, but yields relatively small direct effects on symptom decline when the effect of pretreatment severity is taken into account. Lippincott Williams & Wilkins 2022-10 2022-04-23 /pmc/articles/PMC9555756/ /pubmed/35471975 http://dx.doi.org/10.1097/NMD.0000000000001535 Text en Copyright © 2022 The Author(s). Published by Wolters Kluwer Health, Inc. https://creativecommons.org/licenses/by/4.0/This is an open access article distributed under the Creative Commons Attribution License 4.0 (CCBY) (https://creativecommons.org/licenses/by/4.0/) , which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Original Articles
van Eeden, Wessel A.
van Hemert, Albert M.
Giltay, Erik J.
Spinhoven, Philip
de Beurs, Edwin
Carlier, Ingrid V.E.
Prognostic Value of Pathological Personality Traits for Treatment Outcome in Anxiety and Depressive Disorders: The Leiden Routine Outcome Monitoring Study
title Prognostic Value of Pathological Personality Traits for Treatment Outcome in Anxiety and Depressive Disorders: The Leiden Routine Outcome Monitoring Study
title_full Prognostic Value of Pathological Personality Traits for Treatment Outcome in Anxiety and Depressive Disorders: The Leiden Routine Outcome Monitoring Study
title_fullStr Prognostic Value of Pathological Personality Traits for Treatment Outcome in Anxiety and Depressive Disorders: The Leiden Routine Outcome Monitoring Study
title_full_unstemmed Prognostic Value of Pathological Personality Traits for Treatment Outcome in Anxiety and Depressive Disorders: The Leiden Routine Outcome Monitoring Study
title_short Prognostic Value of Pathological Personality Traits for Treatment Outcome in Anxiety and Depressive Disorders: The Leiden Routine Outcome Monitoring Study
title_sort prognostic value of pathological personality traits for treatment outcome in anxiety and depressive disorders: the leiden routine outcome monitoring study
topic Original Articles
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9555756/
https://www.ncbi.nlm.nih.gov/pubmed/35471975
http://dx.doi.org/10.1097/NMD.0000000000001535
work_keys_str_mv AT vaneedenwessela prognosticvalueofpathologicalpersonalitytraitsfortreatmentoutcomeinanxietyanddepressivedisorderstheleidenroutineoutcomemonitoringstudy
AT vanhemertalbertm prognosticvalueofpathologicalpersonalitytraitsfortreatmentoutcomeinanxietyanddepressivedisorderstheleidenroutineoutcomemonitoringstudy
AT giltayerikj prognosticvalueofpathologicalpersonalitytraitsfortreatmentoutcomeinanxietyanddepressivedisorderstheleidenroutineoutcomemonitoringstudy
AT spinhovenphilip prognosticvalueofpathologicalpersonalitytraitsfortreatmentoutcomeinanxietyanddepressivedisorderstheleidenroutineoutcomemonitoringstudy
AT debeursedwin prognosticvalueofpathologicalpersonalitytraitsfortreatmentoutcomeinanxietyanddepressivedisorderstheleidenroutineoutcomemonitoringstudy
AT carlieringridve prognosticvalueofpathologicalpersonalitytraitsfortreatmentoutcomeinanxietyanddepressivedisorderstheleidenroutineoutcomemonitoringstudy